Page 95 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

BIOMARKERS FOR DIAGNOSING ASTHMA: NOT QUITE A SMOKING GUN?
REFERENCES
1. Thomson NC, Chaudhuri R, Heaney LG, Bucknall C, Niven RM, Brightling CE, et al. Clinical outcomes and in ammatory biomarkers in current smokers and exsmokers with severe asthma. Journal of Allergy and Clinical Immunology 2013; 131:1008-16.
2. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41:716-26.
3. Westerhof GA, Vollema EM, Weersink EJ, Reinartz SM, de Nijs SB, Bel EH. Predictors for the development of progressive severity in new-onset adult asthma. J Allergy Clin Immunol 2014.
4. Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, Piacen ni G, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med 2014; 108:830-41.
5. Sunyer J, Springer G, Jamieson B, Conover C, Detels R, Rinaldo C, et al. E ects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy 2003; 33:1500-5.
6. Barnes PJ. Cor costeroid resistance in pa ents with asthma and chronic obstruc ve pulmonary disease. J Allergy Clin Immunol 2013; 131:636-45.
7. Giovannelli J, Cherot-Kornobis N, Hulo S, Ciuchete A, Clement G, Amouyel P, et al. Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers. Clin Exp Allergy 2015.
8. Malinovschi A, Backer V, Harving H, Porsbjerg C. The value of exhaled nitric oxide to iden fy asthma in smoking pa ents with asthma-like symptoms. Respir Med 2012; 106:794-801.
9. Toren K, Palmqvist M, Lowhagen O, Balder B, Tunsater A. Self-reported asthma was biased in rela on to disease severity while reported year of asthma onset was accurate. J Clin Epidemiol 2006; 59:90-3.
10. Hekking PP, Bel EH. Developing and emerging clinical asthma phenotypes. J Allergy Clin Immunol Pract 2014; 2:671-80; quiz 81.
11. Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, et al. Measurement of exhaled nitric oxide concentra on in asthma: a systema c review and economic evalua on of NIOX MINO, NIOX VERO and NObreath. Health Technol Assess 2015; 19:1-330.
12. Bossuyt PM, Irwig L, Craig J, Glasziou P. Compara ve accuracy: assessing new tests against exis ng diagnos c pathways. Bmj 2006; 332:1089-92.
13. Moons KG, de Groot JA, Linnet K, Reitsma JB, Bossuyt PM. Quan fying the added value of a diagnos c test or marker. Clin Chem 2012; 58:1408-17.
14. Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, et al. Diagnos c accuracy of minimally invasive markers for detec on of airway eosinophilia in asthma: a systema c review and meta-analysis. Lancet Respir Med 2015; 3:290-300.
15. Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, et al. Biomarkers to iden fy sputum eosinophilia in di erent adult asthma phenotypes. Eur Respir J 2015; 46:688-96.
16. Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected pa ents. Eur Respir J 2008; 31:539-46.
17. Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, et al. High blood eosinophil count is a risk factor for future asthma exacerba ons in adult persistent asthma. J Allergy Clin Immunol Pract 2014; 2:741-50.
18. Tran TN, Khatry DB, Ke X, Ward CK, Gossage D. High blood eosinophil count is associated with more frequent asthma a acks in asthma pa ents. Ann Allergy Asthma Immunol 2014; 113:19-24.
19. Petsky HL, Kynaston JA, Turner C, Li AM, Cates CJ, Lasserson TJ, et al. Tailored interven ons based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database of Systema c Reviews 2007.
93